RAAPID develops AI-powered risk adjustment solutions for healthcare payers, providers, and supporting organizations. The company's HITRUST-certified platform uses Neuro-Symbolic AI to identify chronic conditions, determine HCC codes, and provide explainable documentation for complete audit defense. Backed by M12 (Microsoft's venture fund), RAAPID serves organizations participating in Medicare Advantage, ACA, Medicare ACO, and Medicaid programs with both retrospective and prospective risk capture capabilities. Founded by healthcare technology veterans with over 20 years of experience, RAAPID is headquartered in Louisville, Kentucky.
The company announced its revenue cycle management roadmap, including new AI capabilities in its flagship platform for prior ...
Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, the drugmaker said. Lilly is ...
HSCC released its latest installment in a series of AI-specific publications aimed at helping healthcare organizations securely ...
The AHA argued that hospitals' use of common online analytics tools serves a legitimate purpose rather than a criminal one, ...
The EHR vendor accused SelfRx of retrieving over 100,000 records for financial gain in the high-profile lawsuit. Now, SelfRx said...
Epic alleged that Health Gorilla's actions could threaten nationwide interoperability efforts. But Health Gorilla says it's ...
The frontier health AI model, owned by Mayo Clinic and deployed by Microsoft, will support clinical decision-making, including ...
A new Health & AI Policy Index reveals a growing health AI governance landscape, but one that is fragmented, creating operational...